M. Kaplan

R. Arora, M. Kaplan, Michael Nelson, 2011, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Phototherapy and Photo-Oxidation in Premature Neonates

D. Stevenson, C. Hammerman, A. Hochman, 2005, Neonatology.

Protective Effect of Bilirubin in Ischemia-Reperfusion Injury in the Rat Intestine

A. Eidelman, M. Caplan, C. Hammerman, 2002, Journal of pediatric gastroenterology and nutrition.

Infants with bilirubin levels of 30 mg/dL or more.

C. Hammerman, M. Kaplan, 2004, Pediatrics.

Comparison of Commercial Screening Tests for Glu- cose-6-Phosphate Dehydrogenase Deficiency in the

B. Rudensky, M. Kaplan, C. Leiter, 1997 .

Recent Developments in the Management of Neonatal Hyperbilirubinemia

C. Hammerman, M. Kaplan, 2000 .

Ibuprofen Versus Continuous Indomethacin in Premature Neonates With Patent Ductus Arteriosus: Is the Difference in the Mode of Administration?

C. Hammerman, M. Schimmel, A. Nir, 2008, Pediatric Research.

Patent Ductus Arteriosus in the Premature Neonate

C. Hammerman, M. Kaplan, 1999 .

Glucose-6-phosphate dehydrogenase deficiency: a hidden risk for kernicterus.

C. Hammerman, M. Kaplan, 2004, Seminars in perinatology.

Hyperbilirubinemia among African American, glucose-6-phosphate dehydrogenase-deficient neonates.

D. Stevenson, J. Hoyer, C. Hammerman, 2004, Pediatrics.

Glucose-6-phosphate dehydrogenase-deficient neonates: A potential cause for concern in North America.

C. Hammerman, M. Kaplan, M. Kaplan, 2000, Pediatrics.

Glucose-6-Phosphate Dehydrogenase Screening in Israel-Arab and Palestinian-Arab Neonates.

C. Hammerman, O. Megged, N. Algur, 2015, The Journal of pediatrics.

Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates.

M. Caplan, M. Wilschanski, C. Hammerman, 2005, The Journal of pediatrics.

Necrotizing Bowel Disease with Candida Peritonitis Following Severe Neonatal Hypothermia

A. Eidelman, M. Kaplan, L. Dollberg, 1990, Acta paediatrica Scandinavica.

Continuous versus multiple rapid infusions of indomethacin: effects on cerebral blood flow velocity.

A. Eidelman, C. Hammerman, M. Schimmel, 1995, Pediatrics.

Managing the patent ductus arteriosus in the premature neonate: a new look at what we thought we knew.

C. Hammerman, A. Bin-Nun, M. Kaplan, 2012, Seminars in perinatology.

Ductal Closure With Paracetamol: A Surprising New Approach to Patent Ductus Arteriosus Treatment

D. Fink, C. Hammerman, M. Schimmel, 2011, Pediatrics.

CONTRIBUTION OF HAEMOLYSIS TO JAUNDICE IN SEPHARDIC JEWISH GLUCOSE‐6‐PHOSPHATE DEHYDROGENASE DEFICIENT NEONATES

C. Hammerman, H. Vreman, M. Kaplan, 1996, British journal of haematology.

Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia.

A. Lahad, E. Beutler, C. Hammerman, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Neonatal jaundice and liver disease

D. Stevenson, R. Wong, E. Sibley, 2011 .

Should we screen newborns for glucose-6-phosphate dehydrogenase deficiency in the United States?

D. Stevenson, A. Stark, V. Bhutani, 2013, Journal of Perinatology.

Association between neonatal hyperbilirubinemia and UDP‐glucuronosyltransferase 1A1 gene polymorphisms

C. Hammerman, M. Kaplan, 2013, Pediatrics international : official journal of the Japan Pediatric Society.

Evaluation of discharge management in the prediction of hyperbilirubinemia: the Jerusalem experience.

C. Hammerman, M. Schimmel, N. Algur, 2007, The Journal of pediatrics.

Prediction of hyperbilirubinemia in near-term and term infants.

A. Fanaroff, D. Stevenson, W. Oh, 2001, Journal of perinatology : official journal of the California Perinatal Association.

Hyperbilirubinemia, hemolysis, and increased bilirubin neurotoxicity.

C. Hammerman, M. Kaplan, R. Bromiker, 2014, Seminars in perinatology.

Pathologic Unconjugated Hyperbilirubinemia, Isoimmunization, Abnormalities of Red Cells and Infections

D. Stevenson, R. Wong, M. Kaplan, 2012 .

Severe Neonatal Hyperbilirubinemia and Kernicterus: Are These Still Problems in the Third Millennium?

C. Hammerman, M. Kaplan, R. Bromiker, 2011, Neonatology.

Understanding severe hyperbilirubinemia and preventing kernicterus: adjuncts in the interpretation of neonatal serum bilirubin.

C. Hammerman, M. Kaplan, 2005, Clinica chimica acta; international journal of clinical chemistry.

Understanding and preventing severe neonatal hyperbilirubinemia: is bilirubin neurotoxity really a concern in the developed world?

C. Hammerman, M. Kaplan, 2004, Clinics in perinatology.

Glucose-6-phosphate dehydrogenase deficiency: a potential source of severe neonatal hyperbilirubinaemia and kernicterus.

C. Hammerman, M. Kaplan, 2002, Seminars in neonatology : SN.

Gilbert's syndrome and hyperbilirubinaemia in ABO-incompatible neonates

C. Hammerman, E. Levy-Lahad, P. Renbaum, 2000, The Lancet.

Imbalance between production and conjugation of bilirubin: a fundamental concept in the mechanism of neonatal jaundice.

D. Stevenson, C. Hammerman, M. Muraca, 2002, Pediatrics.

Quantitative neonatal glucose-6-phosphate dehydrogenase screening: distribution, reference values, and classification by phenotype.

C. Hammerman, N. Algur, M. Kaplan, 2012, The Journal of pediatrics.

Glucose-6-phosphate dehydrogenase deficiency and severe neonatal hyperbilirubinemia: a complexity of interactions between genes and environment.

C. Hammerman, M. Kaplan, 2010, Seminars in fetal & neonatal medicine.

Amelioration of ischemia-reperfusion injury in rat intestine by pentoxifylline-mediated inhibition of xanthine oxidase.

A. Eidelman, M. Caplan, C. Hammerman, 1999, Journal of pediatric gastroenterology and nutrition.

SERUM SICKNESS-LIKE REACTIONS TO CEFACLOR: ROLE OF HEPATIC METABOLISM AND INDIVIDUAL SUSCEPTIBILITY

C. Randolph, M. Kaplan, 1995, Pediatrics.

Expectant Management of Midtrimester Premature Rupture of Membranes: A Plea for Limits

A. Samueloff, S. Grisaru-Granovsky, M. Kaplan, 2003, Journal of Perinatology.

Improved prognosis in severely hypothermic newborn infants treated by rapid rewarming.

A. Eidelman, M. Kaplan, 1984, The Journal of pediatrics.

Effect of vitamin K1 on glucose-6-phosphate dehydrogenase deficient neonatal erythrocytes in vitro

D. Waisman, C. Hammerman, N. Meyerstein, 1998, Archives of disease in childhood. Fetal and neonatal edition.

Natural history of early neonatal bilirubinemia: a global perspective

M. Kaplan, M. Maisels, 2021, Journal of Perinatology.

Neonatal hyperbilirubinaemia: a global perspective.

B. Olusanya, T. Hansen, M. Kaplan, 2018, The Lancet. Child & adolescent health.

Predischarge Bilirubin Screening in Glucose-6-Phosphate Dehydrogenase-Deficient Neonates

C. Hammerman, M. Kaplan, Cathy Hammerman, 2000, Pediatrics.

HEMOLYSIS AND HYPERBILIRUBINEMIA IN ABO BLOOD GROUP HETEROSPECIFIC NEONATES

D. Stevenson, R. Wong, C. Hammerman, 2010 .

Onset of jaundice in glucose-6-phosphate dehydrogenase-deficient neonates.

C. Hammerman, N. Algur, M. Kaplan, 2001, Pediatrics.

Hyperbilirubinaemia, glucose-6-phosphate dehydrogenase deficiency and Gilbert syndrome

E. Beutler, C. Hammerman, M. Kaplan, 2001, European Journal of Pediatrics.

Comparative Tolerability of Pharmacological Treatments for Patent Ductus Arteriosus

C. Hammerman, M. Kaplan, 2001, Drug safety.

The Preterm Infant: A High-Risk Situation for Neonatal Hyperbilirubinemia Due to Glucose-6-Phosphate Dehydrogenase Deficiency.

V. Bhutani, C. Hammerman, M. Kaplan, 2016, Clinics in perinatology.

Point-of-Care Quantitative Measure of Glucose-6-Phosphate Dehydrogenase Enzyme Deficiency

Michael Kaplan, Bertil Glader, Vamsee Pamula, 2015, Pediatrics.

Hyperbilirubinemia in black infants.

C. Hammerman, M. Kaplan, 2013, Jornal de Pediatria.

Neonatal hyperbilirubinemia in African American males: the importance of glucose-6-phosphate dehydrogenase deficiency.

D. Stevenson, G. Heller, J. Hoyer, 2006, The Journal of pediatrics.

Neonatal screening for glucose-6-phosphate dehydrogenase deficiency: biochemical versus genetic technologies.

C. Hammerman, M. Kaplan, 2011, Seminars in perinatology.

Fatal kernicterus in a girl deficient in glucose-6-phosphate dehydrogenase: a paradigm of synergistic heterozygosity.

D. Kidron, T. Gelbart, N. Roy‐Chowdhury, 2009, The Journal of pediatrics.

(TA)n UDP-Glucuronosyltransferase 1A1 Promoter Polymorphism in Nigerian Neonates

T. Slusher, C. Hammerman, E. Levy-Lahad, 2008, Pediatric Research.

Hemolysis and Hyperbilirubinemia in an African American Neonate Heterozygous for Glucose-6-Phosphate Dehydrogenase Deficiency

T. Gelbart, M. Herschel, M. Kaplan, 2002, Journal of Perinatology.

Bilirubin conjugation, reflected by conjugated bilirubin fractions, in glucose-6-phosphate dehydrogenase-deficient neonates: a determining factor in the pathogenesis of hyperbilirubinemia.

C. Hammerman, M. Muraca, B. Rudensky, 1998, Pediatrics.

Prediction of Hyperbilirubinemia in Near-Term and Term Infants

A. Fanaroff, D. Stevenson, W. Oh, 2001, Journal of Perinatology.

Hemolysis and hyperbilirubinemia in antiglobulin positive, direct ABO blood group heterospecific neonates.

D. Stevenson, R. Wong, C. Hammerman, 2010, The Journal of pediatrics.

Post-phototherapy neonatal bilirubin rebound: a potential cause of significant hyperbilirubinaemia

A. Eidelman, C. Hammerman, M. Schimmel, 2005, Archives of Disease in Childhood.

Neonatal Hyperbilirubinemia in the Low-Intermediate–Risk Category on the Bilirubin Nomogram

C. Hammerman, M. Schimmel, A. Bin-Nun, 2012, Pediatrics.

Successful treatment of neonatal Flavobacterium meningosepticum infection

D. Sompolinsky, F. Solomon, M. Kaplan, 1983, European Journal of Pediatrics.

97 – Hereditary Contribution to Neonatal Hyperbilirubinemia

C. Hammerman, M. Kaplan, 2017 .

Neonatal hyperbilirubinemia associated with glucose-6-phosphate dehydrogenase deficiency in Sephardic-Jewish neonates: incidence, severity, and the effect of phototherapy.

M. Kaplan, A. Abramov, 1992, Pediatrics.

Unconjugated and Conjugated Bilirubin Pigments during Perinatal Development

C. Hammerman, M. Muraca, M. Vilei, 1986, Neonatology.

Onset of jaundice in G6PD deficient neonates.

C. Hammerman, M. Kaplan, 2006, Indian pediatrics.

Bilirubin genetics for the nongeneticist: hereditary defects of neonatal bilirubin conjugation.

C. Hammerman, M. Kaplan, M. Maisels, 2003, Pediatrics.

Apparent intrauterine fetal withdrawal from clomipramine hydrochloride.

M. Kaplan, R. Bromiker, 1994, JAMA.

(TA)n UGT 1A1 Promoter Polymorphism: A Crucial Factor in the Pathophysiology of Jaundice in G-6-PD Deficient Neonates

D. Stevenson, R. Wong, C. Hammerman, 2007, Pediatric Research.

Indomethacin Tocolysis Increases Postnatal Patent Ductus Arteriosus Severity

A. Eidelman, C. Hammerman, M. Schimmel, 1998, Pediatrics.

Clustering of conjoined twins in Jerusalem, Israel: an epidemiologic survey.

A. Eidelman, M. Kaplan, 1983, American journal of obstetrics and gynecology.

Early cardiac evaluation of thoracically conjoined twins.

A. Eidelman, M. Kaplan, J. Glaser, 1983, Cardiology.

Direct Antiglobulin Titer Strength and Hyperbilirubinemia

D. Stevenson, R. Wong, C. Hammerman, 2014, Pediatrics.

Grand Rounds Hyperbilirubinemia Following Phototherapy In Glucose-6-Phosphate Dehydrogenase Deficient Neonates: Not Out Of The Woods.

C. Hammerman, S. Shapiro, M. Kaplan, 2023, The Journal of pediatrics.

Surrogate Outcomes: An Inevitable Limitation of Hyperbilirubinemia-Driven Randomized Controlled Trials.

C. Hammerman, M. Kaplan, 2020, Neonatology.

Israel guidelines for the management of neonatal hyperbilirubinemia and prevention of kernicterus

P. Merlob, R. Regev, M. Kaplan, 2008, Journal of Perinatology.

Studies in hemolysis in glucose-6-phosphate dehydrogenase-deficient African American neonates.

D. Stevenson, J. Hoyer, T. Karrison, 2006, Clinica chimica acta; international journal of clinical chemistry.

Differing Pathogenesis of Perinatal Bilirubinemia in Glucose-6-Phosphate Dehydrogenase-Deficient Versus-Normal Neonates

D. Stevenson, C. Hammerman, E. Levy-Lahad, 2001, Pediatric Research.

Arteriosus Treatment Ductal Closure With Paracetamol : A Surprising New Approach to Patent Ductus

D. Fink, C. Hammerman, M. Schimmel, 2011 .

Influence of hyperbilirubinemia on neonatal sucking.

B. Medoff‐Cooper, M. Kaplan, R. Bromiker, 2016, Early human development.

Somatic Growth of Preterm Infants During Skin‐to‐Skin Care Versus Traditional Holding: A Randomized, Controlled Trial

R. Ehrenkranz, L. Mayes, E. Sherwonit, 2003, Journal of developmental and behavioral pediatrics : JDBP.

Kernicterus on the Spectrum.

C. Hammerman, Yair Kasirer, M. Kaplan, 2023, NeoReviews.

A New Hour-Specific Serum Bilirubin Nomogram for Neonates ≥35 Weeks of Gestation.

M. J. Maisels, T. Newman, M. Kaplan, 2021, The Journal of pediatrics.

N-terminal-Pro-B-Type Natriuretic Peptide in Premature Patent Ductus Arteriosus: A Physiologic Biomarker, But Is It a Clinical Tool?

C. Hammerman, M. Schimmel, A. Nir, 2009, Pediatric Cardiology.

Letter to The Editor

C. Hammerman, M. Kaplan, 2000, Journal of Perinatology.

Might Bilirubin Serve as a Natural Antioxidant in Response to Neonatal Encephalopathy?

F. Mimouni, C. Hammerman, M. Schimmel, 2018, American Journal of Perinatology.

Heme Oxygenase-1 Promoter Polymorphisms and Neonatal Jaundice

D. Stevenson, R. Wong, C. Hammerman, 2014, Neonatology.

Hyperbilirubinemia in the Term Infant: Re-evaluating What We Think We Know.

C. Hammerman, M. Kaplan, 2021, Clinics in perinatology.

Hemolysis and Glucose-6-Phosphate Dehydrogenase Deficiency-Related Neonatal Hyperbilirubinemia

D. Stevenson, R. Wong, M. Kaplan, 2018, Neonatology.

Gilbert's syndrome and jaundice in glucose-6-phosphate dehydrogenase deficient neonates.

M. Kaplan, 2000, Haematologica.

Visual screening versus transcutaneous bilirubinometry for predischarge jaundice assessment

C. Hammerman, M. Schimmel, N. Algur, 2008, Acta paediatrica.

Haemolytic and nonhaemolytic jaundice revisited

M. Kaplan, 2017, Acta paediatrica.

Failure to Predict Hemolysis and Hyperbilirubinemia by IgG Subclass in Blood Group A or B Infants Born to Group O Mothers

D. Stevenson, R. Wong, C. Hammerman, 2009, Pediatrics.

Glucose-6-phosphate dehydrogenase activity in term and near-term, male African American neonates.

D. Stevenson, J. Hoyer, C. Hammerman, 2005, Clinica chimica acta; international journal of clinical chemistry.

Post factum imposition of exchange transfusion criteria: in defence of neonatologists

A. Eidelman, M. Kaplan, 2011, Acta paediatrica.

EFFICACY AND SAFETY OF HYDROLYZED COW MILK AND AMINO ACID-DERIVED FORMULAS IN INFANTS WITH COW MILK ALLERGY

M. Kaplan, T. Pham, 1996, Pediatrics.

Elective High-Frequency Oscillatory Ventilation versus Conventional Ventilation for Acute Pulmonary Dysfunction in Preterm Infants

Sung-il Cho, W. Hop, N. Marlow, 2012, Neonatology.

Failure of varicella‐zoster immunoglobulin in modification of severe congenital varicella

A. Gershon, M. Hammerschlag, S. Bakshi, 1986, Pediatric infectious disease.

Unconjugated and conjugated bilirubin pigments during perinatal development. V. Effect of phototherapy on serum conjugated bilirubin in hyperbilirubinemic neonates.

C. Hammerman, M. Muraca, M. Vilei, 1998, Biology of the neonate.

Neonatal hypoglycemia related to umbilical artery catheter malposition.

O. Blondheim, H. Hirsch, M. Kaplan, 1985, The Journal of pediatrics.

Bilirubin in the premature: toxic waste or natural defense?

Hammerman, A. Eidelman, C. Hammerman, 1998, Clinical chemistry.

Severe neonatal hyperbilirubinemia. A potential complication of glucose-6-phosphate dehydrogenase deficiency.

C. Hammerman, M. Kaplan, Cathy Hammerman, 1998, Clinics of Perinatology.

Direct Antiglobulin Titer Strength and Hyperbilirubinemia

D. Stevenson, R. Wong, C. Hammerman, 2014, Pediatrics.

Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates.

M. Caplan, M. Wilschanski, C. Hammerman, 2005, The Journal of pediatrics.

Exchange transfusion for neonatal hyperbilirubinemia with glucose ‑ 6 ‑ phosphate ‑ deficient blood

C. Hammerman, M. Kaplan, 2009 .

Variation in Transcutaneous Bilirubin Nomograms across Population Groups.

M. Kaplan, R. Bromiker, 2019, The Journal of pediatrics.

American Academy of Pediatrics guidelines for detecting neonatal hyperbilirubinaemia and preventing kernicterus

C. Hammerman, M. Kaplan, 2005, Archives of Disease in Childhood - Fetal and Neonatal Edition.

Steroid Therapy and the Treatment of Bronchopulmonary Dysplasia: an Error in Neonatology, or an Unavoidable Therapeutic Intervention?

M. Kaplan, 2004, Journal of Perinatology.

Post‐discharge neonatal hyperbilirubinemia surveillance

C. Stein-Zamir, H. Shoob, D. Zimmerman, 2019, Acta paediatrica.

Ductal Closure With Paracetamol: A Surprising New Approach to Patent Ductus Arteriosus Treatment

D. Fink, C. Hammerman, M. Schimmel, 2011, Pediatrics.

Primum non nocere: prophylactic versus curative ibuprofen

M. Kaplan, Cathy Hammerman, 2004, The Lancet.

Familial hyperbilirubinemia in ABO-incompatible neonates.

C. Hammerman, M. Kaplan, 2003, Pediatrics.

Glucose-6-Phosphate Dehydrogenase Deficiency: A Worldwide Potential Cause of Severe Neonatal Hyperbilirubinemia

C. Hammerman, M. Kaplan, 2000 .